Literature DB >> 434994

Intravenous antibiotic therapy at home.

A C Kind, D N Williams, G Persons, J A Gibson.   

Abstract

Many patients who are hospitalized for intensive intravenous (IV) antibiotic therapy of serious infections are not disabled. Following a short period of treatment in the hospital and after their medical problem has stabilized, these patients can safety receive IV antibiotics at home. Patients who had osteomyelitis or infective endocarditis were selected for this study. Utilizing an IV nurse team, patients were instructed in the administration of the antibiotic. They returned to the hospital every 48 hours to have their IV catheter changed and to receive a new supply of antibiotic. There was a substantial monetary saving with each treatment course (at least $1,600 per patient), and, in addition, the patients were much more comfortable at home and some returned to work or to school.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434994

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

2.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

3.  Home management of intravenous antibiotic therapy.

Authors:  D M Poretz
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

4.  Intramuscular ceftriaxone in home parenteral therapy.

Authors:  T A Russo; S Cook; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Self-administration of intravenous antibiotics: an efficient, cost-effective home care program.

Authors:  H G Stiver; S K Trosky; D D Cote; J L Oruck
Journal:  Can Med Assoc J       Date:  1982-08-01       Impact factor: 8.262

6.  Willingness to pay to assess patient preferences for therapy in a Canadian setting.

Authors:  Carlo A Marra; Luciana Frighetto; Alan F Goodfellow; Amy O Wai; M Lynn Chase; Ruth E Nicol; Carole A Leong; Sally Tomlinson; Barbara M Ferreira; Peter J Jewesson
Journal:  BMC Health Serv Res       Date:  2005-06-07       Impact factor: 2.655

7.  Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.

Authors:  Russell M Petrak; Nathan C Skorodin; Robert M Fliegelman; David W Hines; Vishnu V Chundi; Brian P Harting
Journal:  Open Forum Infect Dis       Date:  2016-10-19       Impact factor: 3.835

8.  Cost-effective antibiotic prescribing.

Authors:  R Gleckman; N M Gantz
Journal:  Pharmacotherapy       Date:  1983 Jul-Aug       Impact factor: 4.705

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.